EUVIMEDEUVIMED entdecken
Open Access

CPEB1 Controls NRF2 Proteostasis and Ferroptosis Susceptibility in Pancreatic Cancer

Shuxia Zhang, Jingnan Huang, Zhangzhang Lan, Yanlin Xiao, Youyou Liao, Shiva Basnet, Piying Huang, Yunze Li, Jingyu Yan, Yuling Sheng, Wenwen Zhou, Qi Liu und 7 weitere

International Journal of Biological Sciences · 2024

DOI: 10.7150/ijbs.95962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Shuxia Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Key University Laboratory of Metabolism and Health of Guangdong, Biochemistry Department, School of Medicine, Southern University of Science and Tech…. Hauptthemen laut MEDLINE: Ferroptosis, Pancreatic Neoplasms, NF-E2-Related Factor 2. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is the deadliest malignancy with a poor response to chemotherapy but is potentially indicated for ferroptosis therapy. Here we identified that cytoplasmic polyadenylation element binding protein 1 (CPEB1) regulates NRF2 proteostasis and susceptibility to ferroptosis in pancreatic ductal adenocarcinoma (PDAC). We found that CPEB1 deficiency in cancer cells promotes the translation of p62/SQSTM1 by facilitating mRNA polyadenylation. Consequently, upregulated p62 enhances NRF2 stability by sequestering KEAP1, an E3 ligase for proteasomal degradation of NRF2, leading to the transcriptional activation of anti-ferroptosis genes. In support of the critical role of this signaling cascade in cancer therapy, CPEB1-deficient pancreatic cancer cells display higher resistance to ferroptosis-inducing agents than their CPEB1-normal counterparts in vitro and in vivo. Furthermore, based on the pathological evaluation of tissue specimens from 90 PDAC patients, we established that CPEB1 is an independent prognosticator whose expression level is closely associated with clinical therapeutic outcomes in PDAC. These findings identify the role of CPEB1 as a key ferroptosis regulator and a potential prognosticator in pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisPancreatic NeoplasmsNF-E2-Related Factor 2HumansCell Line, TumorAnimalsmRNA Cleavage and Polyadenylation FactorsMiceProteostasisTranscription FactorsCarcinoma, Pancreatic DuctalKelch-Like ECH-Associated Protein 1Mice, Nude

Stichwörter der Autor:innen

CPEB1NRF2ferroptosisp62/SQSTM1pancreatic cancer

Substanzen

NF-E2-Related Factor 2CPEB1 protein, humanmRNA Cleavage and Polyadenylation FactorsTranscription FactorsNFE2L2 protein, humanKelch-Like ECH-Associated Protein 1

Autor:innen und Institutionen

  • Key University Laboratory of Metabolism and Health of Guangdong, Biochemistry Department, School of Medicine, Southern University of Science and Technology, 1088 Xueyuan Avenue, Shenzhen, Guangdong 518055, P.R. China.
  • Department of Gastroenterology, The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, 1017 Dongmen North Road, Shenzhen, Guangdong 518020, P.R. China.
  • Department of Geriatrics, and Shenzhen Clinical Research Centre for Geriatrics, The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, 1017 Dongmen North Road, Shenzhe…
  • School of Medicine, Southern University of Science and Technology, 1088 Xueyuan Avenue, Shenzhen, Guangdong 518055, P.R. China.
  • Clinical laboratory, Southern University of Science and Technology Hospital, 6019 Liuxian Street, Xili Avenue, Shenzhen, Guangdong 518055, P.R. China.
  • Beijing Tsinghua Changgung Hospital & Tsinghua University School of Medicine, 168 Litang Road, Changping District, Beijing 102218, P.R. China.

Zitieren

APA

Zhang, S., Huang, J., Lan, Z., Xiao, Y., Liao, Y., Basnet, S., Huang, P., Li, Y., Yan, J., Sheng, Y., Zhou, W., Liu, Q., Tan, H., Tan, Y., Yuan, L., Wang, L., Dai, L., Zhang, W., & Du, C. (2024). CPEB1 Controls NRF2 Proteostasis and Ferroptosis Susceptibility in Pancreatic Cancer. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.95962

Vancouver

Zhang S, Huang J, Lan Z, Xiao Y, Liao Y, Basnet S, et al. CPEB1 Controls NRF2 Proteostasis and Ferroptosis Susceptibility in Pancreatic Cancer. International Journal of Biological Sciences. 2024. doi:10.7150/ijbs.95962

BibTeX
@article{Zhang2024,
  author = {Zhang, Shuxia and Huang, Jingnan and Lan, Zhangzhang and Xiao, Yanlin and Liao, Youyou and Basnet, Shiva and Huang, Piying and Li, Yunze and Yan, Jingyu and Sheng, Yuling and Zhou, Wenwen and Liu, Qi and Tan, Haoyuan and Tan, Yi and Yuan, Leyong and Wang, Lisheng and Dai, Lingyun and Zhang, Wenyong and Du, Changzheng},
  title = {CPEB1 Controls NRF2 Proteostasis and Ferroptosis Susceptibility in Pancreatic Cancer},
  journal = {International Journal of Biological Sciences},
  year = {2024},
  doi = {10.7150/ijbs.95962}
}
Kostenlos starten →